Literature DB >> 30953604

Hepatitis C Virus Infection and Cholangiocarcinoma: An Insight into Epidemiologic Evidences and Hypothetical Mechanisms of Oncogenesis.

Maria-Cristina Navas1, Shannon Glaser2, Harshil Dhruv3, Scott Celinski4, Gianfranco Alpini2, Fanyin Meng5.   

Abstract

Hepatitis C virus (HCV) infection is a global public health problem because it is a main cause of liver cirrhosis and hepatocellular carcinoma. This human oncogenic virus is also associated with the development of non-Hodgkin lymphoma and cholangiocarcinoma (CCA). The association between HCV infection and CCA has been examined in a number of epidemiologic studies. However, in vivo and in vitro results demonstrating the oncogenic mechanisms of HCV in CCA development and progression are insufficient. Here, we review the epidemiologic association of HCV and CCA and recent publications of studies of HCV infection of cholangiocytes and CCA cell lines as well as studies of viral infection performed with liver samples obtained from patients. In addition, we also discuss the preliminary results of in vitro assays of HCV protein expression in CCA cell lines. Finally, we discuss the hypothetical role of HCV infection in CCA development by induction of epithelial-mesenchymal transition and up-regulation of hedgehog signaling, and consequently biliary tree inflammation and liver fibrosis. Further studies are required to demonstrate these hypotheses and therefore to elucidate the mechanisms of HCV as a risk factor for CCA.
Copyright © 2019 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID: 30953604     DOI: 10.1016/j.ajpath.2019.01.018

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  4 in total

Review 1.  Cancer Vaccines: Antigen Selection Strategy.

Authors:  Yue Zhao; Alexey V Baldin; Orkhan Isayev; Jens Werner; Andrey A Zamyatnin; Alexandr V Bazhin
Journal:  Vaccines (Basel)       Date:  2021-01-25

2.  High BLM Expression Predicts Poor Clinical Outcome and Contributes to Malignant Progression in Human Cholangiocarcinoma.

Authors:  Xiaolong Du; Chen Zhang; Chuanzheng Yin; Wenjie Wang; Xueke Yan; Dawei Xie; Xichuan Zheng; Qichang Zheng; Min Li; Zifang Song
Journal:  Front Oncol       Date:  2021-03-22       Impact factor: 6.244

3.  Secular trends of intrahepatic cholangiocarcinoma in a high endemic area: A population-based study.

Authors:  Chun-Ru Lin; Yu-Kwang Lee; Chun-Ju Chiang; Ya-Wen Yang; Hung-Chuen Chang; San-Lin You
Journal:  World J Gastroenterol       Date:  2022-07-28       Impact factor: 5.374

4.  Comparison of liver biopsies before and after direct-acting antiviral therapy for hepatitis C and correlation with clinical outcome.

Authors:  Omar A Saldarriaga; Bradley Dye; Judy Pham; Timothy G Wanninger; Daniel Millian; Michael Kueht; Benjamin Freiberg; Netanya Utay; Heather L Stevenson
Journal:  Sci Rep       Date:  2021-07-15       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.